Bioprojet   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Paris France (1981)

Organization Overview

First Clinical Trial
2007
NCT00642928
First Marketed Drug
2019
pitolisant (Wakix)
First NDA Approval
2019
pitolisant (Wakix)
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Bioprojet | Bioprojet Pharma